Cite

HARVARD Citation

    Gerdts, E. et al. (2015). Development and optimization of PSCA-specific CAR T cells for the treatment of bone metastatic prostate cancer. Journal for immunotherapy of cancer. 3 (2), p. 1. [Online]. 
  
Back to record